XYLT1 and skeletal dysplasia: Expansions in XYLT1 were uncovered using a combination of genome sequencing, microarray analysis, and Sanger sequencing in patients with Baratela-Scott syndrome (BSS), another skeletal dysplasia sharing many clinical features with DBQD2.